Gijsbers Kim M, van der Schee Lisa, van Veen Tessa, van Berkel Annemarie M, Boersma Femke, Bronkhorst Carolien M, Didden Paul D, Haasnoot Krijn J C, Jonker Anne M, Kessels Koen, Knijn Nikki, van Lijnschoten Ineke, Mijnals Clinton, Milne Anya N, Moll Freek C P, Schrauwen Ruud W M, Schreuder Ramon-Michel, Seerden Tom J, Spanier Marcel B W M, Terhaar Sive Droste Jochim S, Witteveen Emma, de Vos Tot Nederveen Cappel Wouter H, Vleggaar Frank P, Laclé Miangela M, Ter Borg Frank, Moons Leon M G
Department of Gastroenterology & Hepatology, University Medical Center Utrecht, Utrecht, The Netherlands.
Department of Gastroenterology & Hepatology, Deventer Hospital, Deventer, The Netherlands.
Endosc Int Open. 2022 Apr 14;10(4):E282-E290. doi: 10.1055/a-1736-6960. eCollection 2022 Apr.
A free resection margin (FRM) > 1 mm after local excision of a T1 colorectal cancer (CRC) is known to be associated with a low risk of local intramural residual cancer (LIRC). The risk is unclear, however, for FRMs between 0.1 to 1 mm. This study evaluated the risk of LIRC after local excision of T1 CRC with FRMs between 0.1 and 1 mm in the absence of lymphovascular invasion (LVI), poor differentiation and high-grade tumor budding (Bd2-3). Data from all consecutive patients with local excision of T1 CRC between 2014 and 2017 were collected from 11 hospitals. Patients with a FRM ≥ 0.1 mm without LVI and poor differentiation were included. The main outcome was risk of LIRC (composite of residual cancer in the local excision scar in adjuvant resection specimens or local recurrence during follow-up). Tumor budding was also assessed for cases with a FRM between 0.1 and 1mm. A total of 171 patients with a FRM between 0.1 and 1 mm and 351 patients with a FRM > 1 mm were included. LIRC occurred in five patients (2.9 %; 95 % confidence interval [CI] 1.0-6.7 %) and two patients (0.6 %; 95 % CI 0.1-2.1 %), respectively. Assessment of tumor budding showed Bd2-3 in 80 % of cases with LIRC and in 16 % of control cases. Accordingly, in patients with a FRM between 0.1 and 1 mm without Bd2-3, LIRC was detected in one patient (0.8%; 95 % CI 0.1-4.4 %). In this study, risks of LIRC were comparable for FRMs between 0.1 and 1 mm and > 1 mm in the absence of other histological risk factors.
已知T1期结直肠癌(CRC)局部切除术后切缘阴性(FRM)>1mm与肠壁内局部残留癌(LIRC)风险低相关。然而,对于FRM在0.1至1mm之间的情况,其风险尚不清楚。本研究评估了在无淋巴管侵犯(LVI)、低分化和高级别肿瘤芽生(Bd2 - 3)的情况下,T1期CRC局部切除术后FRM在0.1至1mm之间时LIRC的风险。收集了201年至2017年期间11家医院所有连续接受T1期CRC局部切除患者的数据。纳入FRM≥0.1mm且无LVI和低分化的患者。主要结局是LIRC风险(辅助切除标本中局部切除瘢痕内残留癌或随访期间局部复发的综合情况)。对于FRM在0.1至1mm之间的病例,也评估了肿瘤芽生情况。共纳入171例FRM在0.1至1mm之间的患者和351例FRM>1mm的患者。LIRC分别发生在5例患者(2.9%;95%置信区间[CI] 1.0 - 6.7%)和2例患者(0.6%;95% CI 0.1 - 2.1%)中。肿瘤芽生评估显示,80%的LIRC病例和16%的对照病例存在Bd2 - 3。因此,在FRM在0.1至1mm之间且无Bd2 - 3的患者中,1例患者检测到LIRC(0.8%;95% CI 0.1 - 4.4%)。在本研究中,在无其他组织学危险因素的情况下,FRM在0.1至1mm之间和>1mm时LIRC风险相当。